International Journal of
Reproductive Biomedicine
Mon, Jan 18, 2021
[Archive]
Volume 11, Issue 3 (5-2013)
IJRM 2013, 11(3): 219-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Suganthi R, Vijesh V, Jayachandran S, Fathima Benazir J A. Multiplex PCR based screening for microdeletions in azoospermia factor region of Y chromosome in azoospermic and severe oligozoospermic south Indian men. IJRM. 2013; 11 (3) :219-0
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-393-en.html
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-393-en.html
1- Department of Biotechnology, Dr. G. R. Damodaran College of Sciences, Coimbatore, 641014, India , sugantham2000@gmail.com
2- Department of Biotechnology, Dr. G. R. Damodaran College of Sciences, Coimbatore, 641014, India
2- Department of Biotechnology, Dr. G. R. Damodaran College of Sciences, Coimbatore, 641014, India
Abstract: (2008 Views)
Background: Y chromosomal microdeletion is an important genetic disorder, which may arise due to intrachromosomal recombination between homologous sequences in the male specific region of the human Y chromosome. It is frequently associated with the quantitative reduction of sperm. The screening for Y chromosomal microdeletions has a great clinical value.
Objective: To develop a sequence tagged site (STS) based multiplex PCR protocol, which could be specific for the rapid detection of AZF deletions and thereby estimating the frequency of AZF sub deletions in infertile South Indian men.
Materials and Methods: In the current study, PCR based Y chromosomal microdeletion screening analysis was performed in 75 men including 30 non-obstructive azoospermic men, 20 severe oligozoospermic, and 25 normozoospermic fertile men (controls) using 15 known STS primer pairs mapped within the AZF locus. Deletion frequency was estimated after successful PCR amplification.
Results: We designed and optimized a STS based multiplex PCR protocol, which could be helpful for the clinicians to detect the Y chromosomal deletions rapidly and specifically. In our study, we estimated an overall deletion frequency of 36%. Among these 12 (40%) were azoospermic and 6 (30%) were oligozoospermic. No microdeletions were observed in normozoospermic fertile men.
Conclusion: Our Study emphasizes the fact that Y chromosomal microdeletion screening tests are unavoidable in the workup of idiopathic male infertility. Mandatory screening for Y deletions should be done in all azoospermic and severe oligozoospermic patients before undergoing assisted reproductive technology.
Objective: To develop a sequence tagged site (STS) based multiplex PCR protocol, which could be specific for the rapid detection of AZF deletions and thereby estimating the frequency of AZF sub deletions in infertile South Indian men.
Materials and Methods: In the current study, PCR based Y chromosomal microdeletion screening analysis was performed in 75 men including 30 non-obstructive azoospermic men, 20 severe oligozoospermic, and 25 normozoospermic fertile men (controls) using 15 known STS primer pairs mapped within the AZF locus. Deletion frequency was estimated after successful PCR amplification.
Results: We designed and optimized a STS based multiplex PCR protocol, which could be helpful for the clinicians to detect the Y chromosomal deletions rapidly and specifically. In our study, we estimated an overall deletion frequency of 36%. Among these 12 (40%) were azoospermic and 6 (30%) were oligozoospermic. No microdeletions were observed in normozoospermic fertile men.
Conclusion: Our Study emphasizes the fact that Y chromosomal microdeletion screening tests are unavoidable in the workup of idiopathic male infertility. Mandatory screening for Y deletions should be done in all azoospermic and severe oligozoospermic patients before undergoing assisted reproductive technology.
Type of Study: Original Article |
References
1. Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment seeking: potential need and demand for infertility medical care. Hum Reprod 2007; 22:1506-1512. [DOI:10.1093/humrep/dem046]
2. World Health Organization .Towards more objectivity in diagnosis and management of male fertility. Int J Androl 1997; 7: 1-53.
3. Dohle GR, Colpi GM, Papp GK, Hargreave TB, Jungwirth A, Weidner W. EAU guidelines on male infertility. Eur Urol 2005; 48: 703-711. [DOI:10.1016/j.eururo.2005.06.002]
4. Sharpe RM, Irvine DS. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health. BMJ 2004; 328:447-451. [DOI:10.1136/bmj.328.7437.447]
5. Krausz C. Genetic Aspects of Male Infertility. Eur Urol Rev 2008; 3: 93-96.
6. Martínez-Garza SG, Gallegos-Rivas MC, Vargas-Maciel M, Rubio-Rubio JM, de Los Monteros-Rodríguez ME, González-Ortega C, et al. Genetic screening in infertile Mexican men: chromosomal abnormalities, Y chromosome deletions, and androgen receptor CAG repeat length. J Androl 2008; 29: 654-660. [DOI:10.2164/jandrol.107.004309]
7. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of a single spermatozoon into an oocyte. Lancet 1992; 340: 17-18. [DOI:10.1016/0140-6736(92)92425-F]
8. Nudel DM, Lipshultz LI. Is Intracytoplasmic Sperm Injection Safe? Current Status and Future Concerns. Curr Uro Rep 2001; 2: 423-431. [DOI:10.1007/s11934-001-0034-8]
9. Kent-First M, Muallem A, Shultz J, Pryor J, Roberts K, Nolten W, et al. Defining regions of the Y-chromosome responsible for male infertility and identification of a fourth AZF region (AZFd) by Y-chromosome microdeletion detection. Mol Reprod Dev 1999; 53: 27-41.
https://doi.org/10.1002/(SICI)1098-2795(199905)53:1<27::AID-MRD4>3.0.CO;2-W [DOI:10.1002/(SICI)1098-2795(199905)53:13.0.CO;2-W]
10. Bonduelle M, Van Assche E, Joris H, Keymolen K, Devroey P, Van Steirteghem A, et al. Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 2002; 17: 2600-2614. [DOI:10.1093/humrep/17.10.2600]
11. Kallen B, Finnstrom O, Nygren KG, Olausson PO. In vitro fertilisation (IVF) in Sweden: risk for congenital malformations after different IVF methods. Birth Defects. Res A Clin Mol Teratol 2005; 73: 162-169.
12. Feng C, Wang LQ, Dong MY, Huang HF. Assisted reproductive technology may increase clinical mutation detection in male offspring. Fertil Steril 2008; 90: 92-96. [DOI:10.1016/j.fertnstert.2007.06.004]
13. Kai CM, Juul A, McElreavey K, Ottesen AM, Garn ID, Main KM, et al. Sons conceived by assisted reproduction techniques inherit deletions in the azoospermia factor (AZF) region of the Y chromosome and the DAZ gene copy number. Hum Reprod 2008; 23: 1669-1678. [DOI:10.1093/humrep/den124]
14. Ferlin A, Arredi B, Speltra E, Cazzadore C, Selice R, Garolla A, et al. Molecular and clinical characterization of Y chromosome microdeletions in infertile men: a 10-year experience in Italy. J Clin Endocrinol Metab 2007; 92: 762-770. [DOI:10.1210/jc.2006-1981]
15. Tiepolo L, Zuffardi, O. Localization of factors controlling spermatogenesis in the nonfluorescent position of the human Y chromosome long arm. Hum Genet 1976; 34: 119-134. [DOI:10.1007/BF00278879]
16. Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, et al. Human Y chromosome azoospermia factors (AZF) mapped to different su